Pituitary desensitization for eight weeks after the administration of two distinct gonadotrophin-releasing hormone agonists

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 126, Issue 1, 2006, Pages 77-80

  Matteo, Maria ^a   Caroppo, Ettore ^b   Gliozheni, Orion ^c   Carone, Domenico ^b   Schonauer, Luca Maria ^b   Vizziello, Giovanni ^b   Greco, Pantaleo ^a   D'Amato, Giuseppe ^b  

^a UNIVERSITY OF FOGGIA   (Italy)

^b NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^c UNIVERSITY OF TIRANA   (Albania)

Author keywords

GnRH analogues; Leuprolin; LH; Pituitary desensitization; Triptorelin

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; LEUPRORELIN; LUTEINIZING HORMONE; TRIPTORELIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESENSITIZATION; ECHOGRAPHY; ENDOMETRIOSIS; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; HORMONAL REGULATION; HORMONE DETERMINATION; HUMAN; HYPOPHYSIS; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUAL CYCLE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TREATMENT DURATION;

EID: 33646470278     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2005.09.018     Document Type: Article

References (15)

1. Balasch J., Jove I.C., Moreno V., Civico S., Puerto B., and Vanrell J.A. The comparison of the two GNRH-a in an in vitro fertilization program. Fertil Steril 58 (1992) 991-994
2. Porcu E., Filicori M., Dal Parto L., Fabbin R., Serachioli R., Colombi C., et al. Comparison between depot leuprorelin and daily buserelin in IVF. J Assist Reprod Genet 12 (1995) 15-19
3. Dada T., Salha O., Baillie H.S., and Sharma V.S. A comparison of three gonadotrophin-releasing hormone analogues in an in vitro fertilization programme: a prospective randomized study. Hum Reprod 14 (1999) 288-293
4. Cheung T., Lo K.W., Lam C.W., Lau W., and Lam P.K. A crossover study of triptorelin and leuprorelin acetate. Fertil Steril 74 (2000) 299-305
5. Vauthier-Brouzes D., and Lefebvre G. Comparison of 3 long ovarian stimulation protocols for in vitro fertilization using a delayed acting GnRH analogue. Contracept Fertil Sex 21 (1993) 209-212
6. Broekmans F.J., Bernardus R.E., Berkhout G., and Shoemaker J. Pituitary and ovarian suppression after early follicular and mid-luteal administration of a LHRH agonist in a depot formation: decapeptyl CR. Gynaecol Endocrinol 6 (1992) 153-161
7. Neuspiller F., Levy M., Remhoi J., Ruiz A., Simon C., and Pellicer A. The use of long and short acting forms of gonadotrophin releasing hormone analogues in women undergoing oocyte donation. Hum Reprod 13 (1998) 1148-1151
8. Orvieto R., Kerner R., Krissi H., Ashkenazi J., Ben Rafael Z., and Bar-Hava I. Comparison of leuprolide acetate and triptorelin in assisted reproductive technology cycles: a prospective randomized study. Fertil Steril 78 (2002) 1268-1271
9. Speroff L, Glass RH, Kase NG. Hormone biosynthesis, metabolism, and mechanism of action. In: Clinical gynecologic endocrinology and infertility. 5th ed., Baltimore: Williams & Wilkins editors; 1994. p. 69.
10. Shoham Z., Jacobs H.S., and Insler V. Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertil Steril 59 (1993) 1153-1161
11. Fleming R., Chung C.C., Yates R.W., and Coutts J.R. Purified urinary follicle stimulating hormone induces different hormonal profiles compared with menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity. Hum Reprod 11 (1996) 1854-1858
12. Loyd F., Herbert M., Fenwick J., Griffiths T., Murdoch A., and Fleming R. Prospective determination of the effects of profound LH suppression on follicular activity and oocyte and embryo function in cycles stimulated with purified FSH. Hum Reprod 12 (1997) 101-102
13. Westergaard L.G., Laursen S.B., and Yding Andersen C. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod 15 (2000) 1003-1008
14. Esposito M.A., Barnhart K.T., Coutifaris C., and Patrizio P. Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle stimulating hormone. Fertil Steril 75 (2001) 519-524
15. Tesarik J., and Mendoza C. Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence. Hum Reprod 17 (2002) 3129-3136